NL7204972A - - Google Patents

Info

Publication number
NL7204972A
NL7204972A NL7204972A NL7204972A NL7204972A NL 7204972 A NL7204972 A NL 7204972A NL 7204972 A NL7204972 A NL 7204972A NL 7204972 A NL7204972 A NL 7204972A NL 7204972 A NL7204972 A NL 7204972A
Authority
NL
Netherlands
Application number
NL7204972A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7204972A publication Critical patent/NL7204972A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/16Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/64Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL7204972A 1971-04-21 1972-04-13 NL7204972A (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13618671A 1971-04-21 1971-04-21
US13818671A 1971-04-21 1971-04-21

Publications (1)

Publication Number Publication Date
NL7204972A true NL7204972A (lt) 1972-10-24

Family

ID=26834087

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7204972A NL7204972A (lt) 1971-04-21 1972-04-13

Country Status (4)

Country Link
DE (1) DE2219408A1 (lt)
FR (1) FR2133979B1 (lt)
GB (1) GB1356763A (lt)
NL (1) NL7204972A (lt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6667300B2 (en) 2000-04-25 2003-12-23 Icos Corporation Inhibitors of human phosphatidylinositol 3-kinase delta
ES2605792T3 (es) 2004-05-13 2017-03-16 Icos Corporation Quinazolinona usada como inhibidor de la fosfatidilinositol 3-quinasa delta humana
WO2010057048A1 (en) 2008-11-13 2010-05-20 Calistoga Pharmaceuticals Inc. Therapies for hematologic malignancies
US9492449B2 (en) 2008-11-13 2016-11-15 Gilead Calistoga Llc Therapies for hematologic malignancies
CN102439012A (zh) 2009-03-24 2012-05-02 吉里德卡利斯托加公司 2-嘌呤基-3-甲苯基-喹唑啉酮衍生物的阻转异构体和使用方法
KR20120005523A (ko) 2009-04-20 2012-01-16 길리아드 칼리스토가 엘엘씨 고형 종양의 치료 방법
AU2010276160A1 (en) 2009-07-21 2012-02-09 Gilead Calistoga Llc Treatment of liver disorders with PI3K inhibitors
NZ603789A (en) * 2010-05-26 2015-03-27 Sunovion Pharmaceuticals Inc Heteroaryl compounds and methods of use thereof
EP3210984B1 (en) 2011-01-11 2019-06-19 Sunovion Pharmaceuticals Inc. Heteroaryl compounds and methods of use thereof
ES2848273T3 (es) 2012-03-05 2021-08-06 Gilead Calistoga Llc Formas polimórficas de (S)-2-(1-(9H-purin-6-ilamino)propilo)-5-fluoro-3-fenilquinazolina-4(3H)-ona
SG11201604825VA (en) 2013-12-20 2016-07-28 Gilead Calistoga Llc Process methods for phosphatidylinositol 3-kinase inhibitors
AU2014364414A1 (en) 2013-12-20 2016-06-30 Gilead Calistoga Llc Polymorphic forms of a hydrochloride salt of (S) -2-(1-(9H-purin-6-ylamino) propyl) -5-fluoro-3-phenylquinazolin-4 (3H) -one
KR20170012560A (ko) 2014-06-13 2017-02-02 길리애드 사이언시즈, 인코포레이티드 포스파티딜이노시톨 3-키나제 억제제
CN111944340B (zh) * 2020-08-21 2022-08-05 无锡市乐卡新材料有限公司 一种耐盐雾防锈涂料

Also Published As

Publication number Publication date
FR2133979A1 (lt) 1972-12-01
GB1356763A (en) 1974-06-12
FR2133979B1 (lt) 1975-10-31
DE2219408A1 (de) 1972-10-26

Similar Documents

Publication Publication Date Title
FR2133979B1 (lt)
AU2658571A (lt)
AU2691671A (lt)
AU465401B2 (lt)
AU2564071A (lt)
AU3005371A (lt)
AU2952271A (lt)
AU2684071A (lt)
AU2941471A (lt)
AU2485671A (lt)
AU2940971A (lt)
AU2654071A (lt)
AU2503871A (lt)
AU2938071A (lt)
AU2486471A (lt)
AU2588771A (lt)
AU2930871A (lt)
AU2473671A (lt)
AU2577671A (lt)
AR192311Q (lt)
AU2684171A (lt)
AU2669471A (lt)
AU3025871A (lt)
AU2963771A (lt)
AU3038671A (lt)